Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 503

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Identification of Serum Soluble ST2 Receptor as a Novel Heart Failure Biomarker

Weinberg, Ellen O., Shimpo, Masahisa, Hurwitz, Shelley, Tominaga, Shin-ichi, Rouleau, Jean-Lucien, Lee, Richard T.·2003·Circulation

Abstract

Background— Using genomic technology, we previously identified an interleukin-1 receptor family member, ST2, as a gene markedly induced by mechanical strain in cardiac myocytes. The soluble receptor form of ST2 is secreted and detectable in human serum. This study tested the hypothesis that soluble ST2 levels in the serum of patients with severe chronic heart failure are increased in patients with neurohormonal activation. Methods and Results— Serum samples, clinical variables, and neurohormone levels from the PRAISE-2 heart failure trial (NYHA functional class III-IV; end point, mortality or transplantation) were analyzed. ST2 serum measurements were performed with ELISA on samples from 161 patients obtained at trial enrollment and from 139 of the same patients obtained 2 weeks after trial enrollment. Baseline ST2 levels were correlated with baseline B-type natriuretic peptide (BNP) levels ( r =0.36, P <0.0001), baseline proatrial natriuretic peptide (ProANP) levels ( r =0.36, P <0.0001), and baseline norepinephrine levels ( r =0.39, P <0.0001). The change in ST2 was significant as a univariate predictor of subsequent mortality or transplantation ( P =0.048), as was baseline BNP ( P <0.0001) and baseline ProANP ( P <0.0001). In multivariate models including BNP and ProANP, the change in ST2 remained significant as a predictor of mortality or transplantation independent of BNP and ProANP. Conclusions— Serum soluble ST2 is a novel biomarker for neurohormonal activation in patients with heart failure. In patients with severe chronic NYHA class III to IV heart failure, the change in ST2 levels is an independent predictor of subsequent mortality or transplantation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000047274.66749.fe

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 503

Metadata

Authors
Weinberg, E. O., Shimpo, M., Hurwitz, S., Tominaga, S.-I., Rouleau, J.-L., & Lee, R. T.
Venue
Circulation
Published
2003-02-11
Volume
107
Issue
5
Pages
721-726
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W1994391038
Cited by
503
References
27
FWCI
3.35
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of Serum Soluble ST2 Receptor as a Novel Heart Failure Biomarker. https://app.cochat.ai/papers/10.1161/01.cir.0000047274.66749.fe
The paper
Weinberg, E. O., Shimpo, M., Hurwitz, S., Tominaga, S.-I., Rouleau, J.-L., & Lee, R. T. (2003). Identification of Serum Soluble ST2 Receptor as a Novel Heart Failure Biomarker. Circulation. https://doi.org/10.1161/01.cir.0000047274.66749.fe

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.